The Yield Growth Corp - President & CEO, Penny White
President & CEO, Penny White
Source: The Georgia Straight
  • Yield Growth (CSE:BOSS) has submitted its second hand sanitiser for approval by Health Canada
  • The sanitiser, Urban Juve will launch in summer of this year, upon receiving approval
  • Health Canada recently loosened and fast-tracked its approval process for hand sanitisers and disinfectants, due to the COVID-19 pandemic 
  • The company has also announced that it will file its end of year financial report on or around April 14
  • Yield Growth (BOSS) is holding steady, with shares trading for $0.21 and a market cap of $21.7 million

Plant-based product developer, Yield Growth (CSE:BOSS) has submitted another hand sanitiser for approval by Health Canada.

This is the second hand sanitiser that the company has developed and submitted for approval. The latest sanitiser is called Urban Juve and takes the form of a liquid spray.

Health Canada recently loosened and fast-tracked its approval process for hand sanitisers and disinfectants. The organisation hopes that this will sure up supply chains throughout the country.

Hand sanitiser is becoming scarce in stores as COVID-19 concerns ramp up demand for the product.

Yield Growth’s President and CEO, Penny White, believes that the new sanitiser is a good addition to the company’s portfolio.

“Our new hand sanitizing gel provides a convenient and effective option for consumers on-the-go. We intend to provide a variety of formulas in several sizes for our customers.

“Yield Growth is well-positioned to take advantage of the rising demand for high-quality, natural products to support good health and fight infectious diseases,” she said.

If Health Canada approves the product, Yield Growth will launch the product this summer.

Alongside this news, the company reported that its cannabis-based operations remain operational and are not at risk from government-mandated shutdowns.

However, despite remaining operational, the company has delayed posting its latest financial results. 

The Canadian Securities Administrators recently granted blanket relief to numerous businesses by allowing them to delay posting financial results.

The CSA hopes that the extra time will allow companies to better adjust for COVID-19’s impact on operations and outlooks.

Yield Growth claims not to have felt any financial effects at the hands of the pandemic. Rather, it claims that operational disruptions have delayed the filing process.

Consequently, the company plans to file its end of year financial statements on or around April 14.

Yield Growth (BOSS) is holding steady, with shares trading for $0.21 at 1:29pm EST.

More From The Market Online

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector.

Sparta and Parametric join forces to advance autonomous medicine project

Sparta Group (TSX.V:SAY) signed a strategic partnership with Parametric Design Canada Inc., a leader in augmented reality (AR) technologies.

MediPharm bolsters revenue with new medical cannabis products

MediPharm Labs (TSX:LABS), a cannabis pharmaceutical stock, increases revenue through a new licensing agreement with Remidose Aerosols.
clinical trial

Sona Nanotech’s therapy shines in cancer trials

Sona Nanotech (CSE:SONA) revels that its targeted hyperthermia therapy has shown positive results in a second preclinical cancer model.